Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · May 23, 2021

Predicting Relapse After Anti-TNF Cessation in Crohn's Disease

Clinical Gastroenterology and Hepatology


Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Gastroenterology and Hepatology
Prediction of Relapse After Anti–Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-Analysis of 1317 Patients From 14 Studies
Clin. Gastroenterol. Hepatol. 2021 Apr 29;[EPub Ahead of Print], RWM Pauwels, C Janneke van der Woude, D Nieboer, EW Steyerberg, MJ Casanova, JP Gisbert, NA Kennedy, CW Lees, E Louis, T Molnár, K Szántó, E Leo, S Bots, R Downey, M Lukas, WC Lin, A Amiot, C Lu, X Roblin, K Farkas, JB Seidelin, M Duijvestein, GR D'Haens, AC de Vries

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading